FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387268000: Prednisolone ophthalmic preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461446019 Prednisolone ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481370010 Prednisolone ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1461446019 Prednisolone ophthalmic preparation (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1461446019 Prednisolone ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481370010 Prednisolone ophthalmic preparation en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1481370010 Prednisolone ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Prednisolone ophthalmic preparation Is a Prednisolone false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Prednisolone sodium phosphate 0.5% single-use eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.001% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.003% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.01% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.01% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.03% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.03% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.1% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.3% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 0.3% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 25mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 50mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 50mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 25mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 1.25 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 10 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate 1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 1% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate 1/8% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate + prednisolone acetate 0ns/0.6%ww ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate + prednisolone acetate 0ns/10%vv suspension (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone-containing product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start